HERCESSI

NDC 69448-016 · Accord BioPharma Inc.

Generic nameTrastuzumab-strf

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)TRASTUZUMAB-STRF

Strength420 mg/20mL

Pharmacologic classHER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]

Marketing categoryBLA

Packages

69448-016-11 — 1 VIAL, MULTI-DOSE in 1 CARTON (69448-016-11) / 20 mL in 1 VIAL, MULTI-DOSE

Q5146 — Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg Medicare Part B payment limit (ASP + 6%): $32.46

FDA lists these products with the same active ingredient.

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.